Uniphar PLC has acquired McCauley

Irish-listed healthcare group Uniphar PLC has acquired Dublin-headquartered McCauley Pharmacy Group, a prominent provider of pharmacy and retail services in Ireland and a market leader in the delivery of health, wellbeing and beauty products.

Uniphar is a global partner to pharmaceutical and medtech manufacturers working to improve patient access to medicines in Europe and around the world. It provides outsourced and specialized services to its clients and leverages strong relationships with over 200 of the world’s best-known pharmaco-medical manufacturers in multiple geographies. Uniphar operates across three core divisions: pharmaceuticals—a global business providing on-demand and medicine-sourcing solutions along with outsourced specialist services to pharmaceutical manufacturers; medtech—a leading European medical device distributor with a presence in 21 markets; and supply chain and retail—a market leader in Ireland with around 50% of the wholesale market and four nationwide pharmacy symbol groups. Uniphar is listed on the LSE and Euronext Dublin.

McCauley Pharmacy Group, a portfolio company of Carlyle Cardinal Ireland, was founded in 1953 as a single family-owned pharmacy store in Wexford, Ireland. The group now has 37 stores across Ireland, with the McCauley store footprint concentrated in the Leinster and Munster regions. The group employs around 450 people across its business, with about 42 staff in its head office and 54 pharmacists. McCauley provides a comprehensive RX and retail offering to the communities it serves. The group also provides a range of additional healthcare services to its customers, such as digital prescriptions, vaccine administration, online doctor services and pharmacist telephone consultations. In addition, McCauley has a significant online and e-commerce presence.

Oaklins’ team in Ireland acted as the exclusive buy-side M&A advisor to Uniphar and assisted in all aspects, from initiating the transaction to structuring and negotiating premium deal terms. This deal complements a long list of acquisitions the team has advised on for Uniphar.